Robert J. Gilkin Jr., Rph, Mba Email & Phone Number

Philadelphia, PA, US

Berwyn, Pennsylvania, US

Williamstown, NJ, US

• Founded and grew a healthcare marketing consulting firm designed to support marketing, rebates, contracting, product launch, and sales initiatives while building clinical and business value in dynamic markets
• Advised and developed market strategies for mature and new biotechnology products for managed care health plans, PBMs, hospitals and health systems, GPOs, wholesalers, and specialty pharmacies
• Captured deals with clients that included Actelion (Janssen), GBT, ChemoCentryx, United Therapeutics, Jazz, and Bausch Health, marketing across diverse therapeutic areas including small and large molecule products and.
• Navigated and prepped for loss of exclusivity (LOE) by building robust payer-focused strategies to manage the life cycle of mature brands
• Spearheaded the development of marketing campaigns and value propositions backed by customer research and in-depth data on health economics to support positioning and payer reimbursement
• Steered marketing and pricing strategy to align sales and account management teams and found and evolved market access functions

Louisville, Kentucky, US

• Charged with P&L responsibility for the HEMA business unit (hematology), representing 80% of company revenue of a family-owned specialty pharmaceutical company focused on hematology, oncology, and addiction treatments
• Increased nets sales by 150% from $20M to $50M within 17 months and on a annual run rate exceeding $100M
• Managed the market access, including the development of a single distribution and HUB model for a 2024 pediatric oncology product launch
• Led a cross-functional team (marketing, sales, commercial operations, trade, market access, finance, supply chain, compliance, legal, finance, human resources, regulatory) to define and execute short-and long-term.
• Supported the alliance management with the company, LFB SA, as a joint venture partner
• Drove the transformation of the HEMA business unit to achieve 30% profit margins by lower operating expenses

Raleigh, NC, US

• Recruited by the CEO to lead on the executive leadership team with oversight of market access and trade strategy development and execution to promote access for all products for a specialty biopharmaceutical company.
• Headed a team of 25 across account management, rebate contracting, patient access, and trade and distribution
• Managed complete scope of pricing and discount and rebate strategy for complete product portfolio
• Partnered with executive leadership to define and execute corporate objectives, forecasts, and sales tactics
• Presented to the Board of Directors and participate on quarterly earnings calls
• Propelled quarterly revenue growth from $6.3M to $21.5M with $71.5M cash balance by improving coverage and affordability to support prescription volume growth while managing gross-to-net (GTN)

Raleigh, NC, US

• Founded market access division to navigate product launch, amplify growth of product pipeline, and explore acquisitions of new products to fuel revenue generation
• Recruited, hired, and mentored a team of 25
• Secured $151M in funding for the acquisition of Aemcolo (travelers’ diarrhea) and Movantik (opioid-induced constipation)
• Partnered on the development of strategic plan, and met with investors and bankers, and defined complete commercial strategy
• Acquired and transitioned Movantik, including all payer agreements, from AstraZeneca
• Retained 100% coverage and removed restrictions to broaden unrestricted coverage to support annual prescription volume exceeding 470K

Laval, Quebec, CA

• Headed a market access team of five with focused leadership on improving unrestricted access and driving pull- and push-through tactics to position company for sale of the biopharmaceutical company focused on the.
• Served on commercial and senior leadership teams driving end-to-end market access strategy and execution
• Positioned in a high-visibility role in front of the board of directors and investors
• Managed rebate processing and pricing for Trulance (irritable bowel syndrome) which was sold for $200M
• Catapulted revenue growth from $5M to $11.1M in a single year
• Doubled unrestricted coverage for Trulance to increase new prescriptions by 46% and grow total volume to $63K

Westbrook, CT, US

• Led team of five with ten subcontractors inside a start-up full-service healthcare marketing agency, leading sales, account management, and business development focused on delivering integrated solutions for.
• Managed product launch P&Ls, payer strategy, industry relationship building, brand pitch development, and data-driven insights
• Showcased agency value to major players, including Jazz, AstraZeneca, Wyeth, Pfizer, and New Haven
• Propelled sales from $3M to $6.5M with 18% margin improvement
• Optimized internal operations and employed payer-focused strategies and HCP messages to overcome barriers to support brand teams
• Launched Pristiq and relaunched Premarin Cream for Wyeth-Pfizer; launched Veletri, Opsumit, & Uptravi (pulmonary atrial hypertension), and Valchlor (T-cell lymphoma) for Actelion; and supported Xyrem (narcolepsy).

Cambridge, Cambridgeshire, GB

• Developed Medicare Part D contracting strategy for portfolio of products
• Primary Lead for Gastroenterology (Nexium) and Cardiovascular (Crestor) franchise

London, GB

• Oversaw a $1B pharmacy budget
• Acted as pharmacy lead for health plan acquisitions and then conversion to corporate formulary and copay design

Philadelphia, PA, US

• Developed and filed the first three-tiered pharmacy benefit design in PA, WV, OH & NJ
• Achieved savings of $5.8M by re-contracting with pharmaceutical manufacturers and retail pharmacies

Indianapolis, Indiana, US

• Tasked as a member of a newly developed team to develop strategies to support the product portfolio to integrated delivery networks and managed care organizations
• Oversaw product promotion, contract management, and relationship building

Philadelphia, Pennsylvania, US

Philadelphia, PA, US

• Restructured a hospital pharmacy department to align with parent organization resulted in $1.2M is savings
• Coordinated a successful Joint Commission on Accreditation of Hospitals (JCAHO) review with accommodation

Philadelphia, Pennsylvania, US

• Managed pharmacy department and front store operations of 20 people
• Oversaw $1M in revenue, improved inventory turnaround by 42%, and increased profitability by 8%

Mba

Pharmacy